Search

everythinglearnresearchcommunity

for

Search:↓

Patients need better counseling and resources for managing chemotherapy-induced hair loss.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Chronic stress can reduce skin pigmentation.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Cooling with antioxidants helps protect hair during chemotherapy.

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

People undergoing chemotherapy need better support and information to cope with hair loss.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

Children with alopecia areata and their caregivers experience significant emotional and quality of life challenges.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Topical corticosteroids can help treat severe alopecia areata when other treatments fail.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Allopregnanolone may help prevent nicotine withdrawal symptoms.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Isotretinoin treatment in Palestine shows poor adherence to guidelines, with common side effects and a need for better prescribing practices and patient education.

Refractory alopecia areata can be managed with medical treatments, psychological support, and aesthetic options.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

No treatment works for everyone, and emotional support is crucial.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.

Topical cyclosporin A doesn't work for alopecia totalis because it doesn't penetrate the skin well.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

Stressful life events may trigger alopecia areata.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Adults with atopic dermatitis showed similar adherence to different forms of hydrocortisone cream, but actual use varied despite self-reports of near-perfect usage.

Hair loss negatively affects self-esteem and social interactions, but people use coping strategies like wigs or shaving to manage it.

Insurers opposed ASCO's recommendation for a single cancer care pathway program.

Corticosteroids and topical irritants are used to treat alopecia areata.

The research explored how children in school view peers with alopecia areata.

Patients with non-small-cell lung cancer need significant survival gains to accept severe side effects.

Isotretinoin is recommended for acne treatment as it is as effective as cyproterone compound.